Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. (Q50467668)

14 March 2018

title

Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. (English)

1 reference

14 March 2018

author name string

Ning Tang

1

1 reference

14 March 2018

Gangjun Du

2

1 reference

14 March 2018

Nan Wang

3

1 reference

14 March 2018

Chunchun Liu

4

1 reference

14 March 2018

Haiying Hang

5

1 reference

14 March 2018

Wei Liang

6

1 reference

14 March 2018

language of work or name

English

0 references

publication date

27 June 2007

1 reference

14 March 2018

Journal of the National Cancer Institute

published in

1 reference

14 March 2018

volume

99

1 reference

14 March 2018

issue

13

1 reference

14 March 2018

page(s)

1004-1015

1 reference

14 March 2018

Angiogenesis in cancer and other diseases

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Engineering vascularized tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Drug delivery and transport to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Lipid-core micelles for targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Labeling and dynamic imaging of synaptic vesicle-like microvesicles in PC12 cells using TIRFM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Endocytosis without clathrin coats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Regulated internalization of caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

21 January 2018

Endocytosis via caveolae

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Therapeutic applications of colloidal drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Inhibition of the Lysosomal Pathway of Protein Degradation in Isolated Rat Hepatocytes by Ammonia, Methylamine, Chloroquine and Leupeptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Use of block copolymers of poly(ortho esters) and poly (ethylene glycol) micellar carriers as potential tumour targeting systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM027

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJM027

1 reference

14 March 2018

PubMed ID

17596572

1 reference

14 March 2018